Clinical Trial Update: Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating pre-operative single-dose ipilimumab and/or cryoablation in early-stage, resectable breast cancer. The study sponsored by Memori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Invasive Adenocarcinoma of the Breast

Drugs mentioned

• Yervoy (Ipilimumab) (Ipilimumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer, Invasive Adenocarcinoma of the Breast | Phase 1 | Status: COMPLETED